Thompson Davis & Co’s DarioHealth DRIO Stock Holding History

Thompson Davis & Co’s Portfolio DRIO Stock Details DRIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-1	Closed	-$2K	–	1101
2017 Q1	$2K	Buy	+1	New	+$1.49K	﹤0.01%	1049

Other funds holding DRIO

Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return

PVH

Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Thompson Davis & Co's DRIO Position: Q2 2017 in Review

Thompson Davis & Co sold out of DarioHealth (DRIO) in Q2 2017, closing a stake of 1 share — an estimated $2K sold.

Thompson Davis & Co first reported a position in DRIO in Q1 2017 and held it in 1 quarter. The position peaked at $2K in Q1 2017. 10 funds tracked by Wall St. Rank hold DRIO as of Q2 2017.

Thompson Davis & Co reported no remaining DarioHealth position as of Q2 2017 after selling out during the quarter.
Thompson Davis & Co sold 1 DarioHealth share in Q2 2017, an estimated $2K.
Thompson Davis & Co first reported a position in DarioHealth in Q1 2017 and held it in 1 quarter.
Thompson Davis & Co's DarioHealth position peaked at $2K in Q1 2017.
10 funds tracked by Wall St. Rank held DarioHealth as of Q2 2017.

Based on Thompson Davis & Co's 13F filing for Q2 2017, filed 10 Aug 2017.